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===============

Under well-fed, resting conditions, glucose stands as the main physiological fuel supporting energy metabolism, growth, and reproduction. However, in naturally encounter environments prolonged episodes of limited food availability and also moderate physical activity dramatically alter blood glucose levels and provoke baseline physiological functions to be more dependent on fatty acids metabolism \[[@bib1]\]. For example, prolonged fasting and endurance exercise cause blood glucose levels to drop while simultaneously lead to increases in ketone bodies at the expense of liver β-oxidation of adipose tissue-derived fatty acids. Also, hepatic ketogenesis---the synthesis of ketone bodies---is enhanced when feeding a high-fat, low-carbohydrate ketogenic diet or in animals undergoing calorie restriction. In any case, the liver takes up and transforms circulating fatty acids into ketone bodies, mainly β-hydroxybutyrate and acetoacetate, which are then exported out to essentially all of the body\'s tissues, including the brain, where they are primarily metabolized via mitochondria to produce adenosine triphosphate (ATP) ([Fig. 1](#fig1){ref-type="fig"}) \[[@bib2]\]. In addition to functioning as alternative energy source during energy stress, it is now well established that β-hydroxybutyrate also moonlights as a signaling molecule \[[@bib2],[@bib3]\] by for example activating the hydroxycarboxylic acid receptor 2 (HCAR2) \[[@bib4]\] and inhibiting the nucleotide binding domain leucine-rich repeat-containing receptor, pyrin domain-containing-3 (NLRP3) inflammasome \[[@bib5]\] on immune cells, thus blocking the synthesis of inflammatory intermediates. In addition, lysine modification by β-hydroxybutyrylation on histone and non-histone proteins is emerging as an important regulator of cellular physiology and metabolism \[[@bib6],[@bib7]\]. Interestingly, β-hydroxybutyrate (and its polymerized form poly-β-hydroxybutyrate) is not solely present in eukarya, but also in bacteria and archaea \[[@bib8]\], suggesting important roles for this widespread molecule on cellular homeostasis.Fig. 1The metabolic and signaling properties of β-hydroxybutyrate. The ketone body β-hydroxybutyrate allows organisms to tolerate systemic energy crisis in response nutritional challenges such as prolonged episodes of limited food availability and moderate physical activity that lead to enhanced free fatty acid oxidation and ketogenesis in hepatic mitochondria. In most extrahepatic tissues, β-hydroxybutyrate is fully oxidized to produce adenosine triphosphate (ATP). β-Hydroxybutyrate also can function as a signaling molecule.Fig. 1

One important aspect of β-hydroxybutyrate that is increasingly been appreciated is its impact on reactive oxygen species (ROS) metabolism. *In vitro* studies have shown that, in the first place, β-hydroxybutyrate functions as a direct antioxidant for hydroxyl radical (•OH) ([Fig. 2](#fig2){ref-type="fig"}A) \[[@bib9]\], and inhibits mitochondrial ROS production in stressed neurons by facilitating NADH oxidation ([Fig. 2](#fig2){ref-type="fig"}B) \[[@bib10]\]. NADH oxidation, and hence the increase of the NAD+/NADH ratio, has important implications in the maintenance of cellular redox homeostasis, for example, through the activation of the protein deacetylases sirtuin 1 (SIRT1) and SIRT3. Convincing evidence has demonstrated that SIRT1 regulates redox status when deacetylates and activates the transcription factor forkhead box O3 (FOXO3), which controls the expression of superoxide dismutase 2 (SOD2) and catalase (CAT). SIRT3, on the other hand, reinforces mitochondrial antioxidant defense by deacetylating and increasing the activity of SOD2. Finally, SIRT3 also activates isocitrate dehydrogenase 2 (IDH2) to increase NADPH, which is used by several antioxidant systems to detoxify ROS \[[@bib11]\]. β-Hydroxybutyrate also protects against highly oxidative stress conditions by driving the expression of heme oxygenase 1 (HO-1), SOD2, CAT, nicotinamide adenine dinucleotide phosphate (NADPH) quinone oxidoreductase 1 (NQO1), glucose-6-phosphate dehydrogenase (G6PDH), and glutamate-cysteine ligase (GCL), through the regulation of FOXO1, FOXO3, and nuclear factor-erythroid 2-related factor-2 (NRF2) ([Fig. 2](#fig2){ref-type="fig"}) \[[@bib12], [@bib13], [@bib14]\]. β-Hydroxybutyrate transcriptionally activates FOXO1 and FOXO3 by promoting histone acetylation due to inhibition of class I histone deacetylases (HDACs). NRF2, on the other hand, seems to be activated by increased amounts of the tricarboxylic acid cycle metabolite fumarate resulting after mitochondrial consumption of β-hydroxybutyrate. However, as an enhanced mitochondrial activity is associated with increased ROS production \[[@bib11]\], it cannot be excluded the possibility that the β-hydroxybutyrate-mediated NRF2 activation likely involves mild increases in ROS generation from the mitochondrial electron transport chain. Overall, the effect of β-hydroxybutyrate on redox homeostasis fits well with the ability of calorie restriction to reduce also oxidative stress and damage \[[@bib15]\].Fig. 2The ketone body β-hydroxybutyrate protects against oxidative stress through direct and indirect mechanisms. β-Hydroxybutyrate is (A) an antioxidant for hydroxyl radicals (•OH) and (B) suppresses mitochondrial reactive oxygen species (ROS). (C) β-Hydroxybutyrate activates an antioxidant program through forkhead box O1 (FOXO1), FOXO3, and nuclear factor-erythroid 2-related factor-2 (NRF2) transcription factors. HO-1: heme oxygenase 1, SOD2: superoxide dismutase 2, CAT: catalase, G6PDH: glucose-6-phosphate dehydrogenase, NQO1: nicotinamide adenine dinucleotide phosphate quinone oxidoreductase 1, γ-GCL: γ-glutamate-cysteine ligase.Fig. 2

*In vivo* experiments have further illustrated that β-hydroxybutyrate is an anti-ischemic molecule. Ischemia follow by reperfusion supposes a tremendous metabolic challenge to cells and tissues leading to severe organ damage and death, owing in large part to oxidative burst \[[@bib16]\]. Administration of β-hydroxybutyrate before or after ischemia and reperfusion results in strong protection of the heart, brain, liver, and the kidney of rodents \[ \[[@bib13],[@bib17], [@bib18], [@bib19]\]\]. Mechanisms like reduction of oxidative stress, but also mitochondrial protection, suppression of endoplasmic reticulum stress, and enhanced autophagy, as well as the inhibition of cell death processes like necrosis, apoptosis, and pyroptosis, account for such protective effect of β-hydroxybutyrate ([Fig. 3](#fig3){ref-type="fig"}). In this case β-hydroxybutyrate also replicates the multi-systemic protective effect of calorie restriction against ischemia and reperfusion-associated injury \[[@bib20]\].Fig. 3The ketone body β-hydroxybutyrate is an anti-ischemic molecule. β-Hydroxybutyrate maintains organ integrity in response to ischemia and reperfusion by suppressing oxidative stress, mitochondrial dysfunction, and inflammation. Also, β-hydroxybutyrate inhibits apoptosis, necrosis, and pyroptosis induced by ischemia and reperfusion. ROS: reactive oxygen species, ER: endoplasmic reticulum.Fig. 3

The exact mechanism linking calorie restriction to enhanced stress resistance, and particularly of reducing oxidative stress, is still missing. It has been hypothesized that β-hydroxybutyrate mediates the beneficial effects of calorie restriction \[[@bib3],[@bib21]\]. This idea seems plausible because in addition to its anti-inflammatory and anti-oxidative properties, β-hydroxybutyrate also leads to lifespan extension \[[@bib17], [@bib18], [@bib19]\]. In fact, besides to FOXO1/3, and NRF2, β-hydroxybutyrate actually seems to interact with signaling pathways activated by reduced nutrient intake, like the adenosine monophosphate (AMP)-activated protein kinase (AMPK) \[[@bib22],[@bib23]\], and SIRT1/3 \[[@bib22],[@bib24]\], and interferes with both insulin \[[@bib25]\] and mammalian target of rapamycin (mTOR) signaling \[[@bib26]\]. Thus, β-hydroxybutyrate helps organisms to overcome stressful/pathological situations by triggering a molecular program for stress resistance similar to calorie restriction \[[@bib27]\] ([Fig. 4](#fig4){ref-type="fig"}).Fig. 4The ketone body β-hydroxybutyrate links calorie restriction and stress resistance. β-Hydroxybutyrate, which is produced during calorie restriction, activates adenosine monophosphate-activated protein kinase (AMPK), sirtuins (SIRTs), forkhead box O (FOXO), and nuclear factor-erythroid 2-related factor-2 (NRF2) stress response signaling pathways while inhibiting insulin and mammalian target of rapamycin (mTOR) signaling. IGF-1: insulin growth factor like-1.Fig. 4

Currently, calorie restriction remains the most powerful tool to increase lifespan in various species \[[@bib27]\]. More importantly, calorie restriction reduces risk of chronic diseases in both experimental animals and humans \[[@bib28]\]. However, implementing a lifelong calorie restriction regimen in the general population is a bit of a challenge. In light of the contribution of oxidative damage in diverse pathologies \[[@bib29]\], increasing physiological amounts of β-hydroxybutyrate might prove useful to promote cellular adaptation to stress and possibly overall human health.
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